◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

VIEMED HEALTHCARE, INC.

CIK: 1729149 SIC: 8090
$270.28M
Revenue
$14.93M
Net Income
57.52%
Gross Margin
8.49%
Op. Margin
$-9.20M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 7 of 7 annual reports available (2019 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
+ Total Revenue $270.28M $270.28M $224.26M $183.01M $138.83M $117.06M $131.31M $80.26M
Revenue Growth % 0.0% 20.5% 22.5% 31.8% 18.6% -10.8% 63.6% nan%
Cost of Revenue $114.82M $114.82M $91.05M $70.22M $54.15M $43.65M $51.20M $24.25M
+ Gross Profit $155.46M $155.46M $133.20M $112.78M $84.68M $73.41M $80.11M $56.01M
Gross Margin % 57.5% 57.5% 59.4% 61.6% 61.0% 62.7% 61.0% 69.8%
Research & Development $3.02M $3.02M $3.07M $2.78M $2.70M $2.11M $1.08M $848.00K
Selling General & Admin $121.37M $121.37M $106.20M $87.88M $68.16M $54.89M $52.83M $41.38M
+ Operating Income $22.95M $22.95M $17.90M $14.33M $8.25M $11.58M $26.78M $8.75M
Operating Margin % 8.5% 8.5% 8.0% 7.8% 5.9% 9.9% 20.4% 10.9%
Interest Expense $1.21M $874.00K $950.00K $851.00K $231.00K $351.00K $559.00K $333.00K
Other Income/Expense $252.00K $252.00K $-173.00K $98.00K $989.00K $1.62M $3.95M $-3.00K
Income Before Tax $21.77M $21.77M $16.17M $14.39M $8.99M $12.50M $26.36M $8.80M
Income Tax Expense $6.39M $6.39M $4.76M $4.15M $2.77M $3.38M $-5.17M $271.00K
+ Net Income $14.93M $14.93M $11.27M $10.24M $6.22M $9.13M $31.53M $8.53M
Net Margin % 5.5% 5.5% 5.0% 5.6% 4.5% 7.8% 24.0% 10.6%
Basic EPS nan 0.38 0.29 0.27 0.16 0.23 0.81 0.23
Diluted EPS nan 0.37 0.28 0.25 0.16 0.22 0.78 0.21
Basic Shares Outstanding -295K 38.9M 38.8M 38.4M 38.7M 39.5M 38.7M 37.7M
Diluted Shares Outstanding -262K 40.8M 40.8M 40.4M 39.8M 40.7M 40.5M 39.7M
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
Cash & Cash Equivalents $13.50M $17.54M $12.84M $16.91M $28.41M $30.98M $13.36M
Accounts Receivable $25.59M $24.91M $18.45M $15.38M $12.82M $12.37M $11.53M
Inventory $5.05M $4.32M $4.63M $3.57M $2.46M $2.31M $1.36M
Other Current Assets $4.13M $6.11M $2.45M $3.85M $1.73M $1.51M $1.56M
Total Current Assets $48.49M $52.88M $38.37M $39.74M $47.31M $47.17M $27.81M
Property Plant & Equipment $78.78M $76.28M $73.58M $67.74M - $55.06M $54.77M
Goodwill $58.94M $32.99M $29.77M - - - -
Intangible Assets $1.28M $848.00K $567.00K - - - -
Other Non-current Assets - - $887.00K $1.59M $862.00K $863.00K $13.00K
Total Assets $199.15M $177.07M $154.90M $117.04M $117.96M $112.56M $82.60M
Accrued Liabilities $23.91M $20.16M $17.58M $11.09M $8.88M $12.60M $8.97M
Deferred Revenue $7.52M $6.69M $6.21M $4.62M $3.75M $3.41M $3.31M
Total Current Liabilities $41.06M $37.33M $32.12M $18.86M $17.81M $23.02M $25.91M
Long-term Debt $11.29M $3.59M $6.00M - $4.31M $5.80M $7.63M
Total Liabilities $55.63M $43.77M $41.00M $19.95M $23.14M $30.87M $38.90M
Common Stock $16.91M $23.36M $18.70M $15.12M $14.01M $9.18M $3.37M
Retained Earnings $102.89M $89.69M $79.50M $69.85M $73.33M $65.64M $34.11M
Total Stockholders Equity $141.54M $131.39M $113.89M $97.09M $94.82M $81.69M $43.70M
Total Liabilities & Equity $199.15M $177.07M $154.90M $117.04M $117.96M $112.56M $82.60M
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
Net Income $17.56M $14.93M $11.27M $10.24M $6.22M $9.13M $31.53M $8.53M
Depreciation & Amortization $48.73M $28.61M $25.37M $21.86M $15.63M - - -
Stock-based Compensation $16.09M $9.13M $6.29M $5.85M $5.20M $5.15M $4.88M $3.89M
Deferred Income Tax - $3.11M $-3.84M $-1.44M $1.75M $3.88M $-8.73M -
Change in Receivables $2.36M $-1.16M $6.07M $1.06M $12.57M $7.34M $9.96M $12.51M
Change in Inventory $135.00K $-59.00K $-574.00K $472.00K $-301.00K $212.00K $2.30M $306.00K
Operating Cash Flow $69.88M $51.92M $39.09M $45.21M $27.75M $22.49M $35.11M $19.09M
Capital Expenditure $79.08M $39.98M $37.77M $26.09M $22.90M $19.74M $13.04M $13.38M
Acquisitions - $26.33M $3.00M $28.59M - - - -
Investing Cash Flow $-68.95M $-50.17M $-30.70M $-52.11M $-23.98M $-19.75M $-8.41M $-12.81M
Debt Repayment - - - - - - - $391.00K
Stock Repurchased - $13.22M - - $9.57M $1.43M - $1.52M
Financing Cash Flow $-9.87M $-5.79M $-3.69M $2.83M $-15.27M $-5.32M $-9.07M $-3.33M
Net Change in Cash $-8.94M $-4.04M $4.70M $-4.08M $-11.49M $-2.57M $17.63M $2.94M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $71.91M - $194.10M -
Cost of Revenue $30.57M - $82.74M -
Gross Profit $41.34M - $111.36M -
Research & Development $775.00K - $2.42M -
Selling General & Admin $31.92M - $89.15M -
Operating Income $5.64M - $14.58M -
Interest Expense - - $587.00K -
Other Income/Expense $44.00K - $191.00K -
Income Before Tax $5.13M - $13.76M -
Income Tax Expense $1.53M - $4.20M -
Net Income $3.51M $1.48M $9.29M -
Basic EPS 0.09 - 0.24 -
Diluted EPS 0.09 - 0.23 -
Basic Shares Outstanding $38.64M - $39.19M -
Diluted Shares Outstanding $40.50M - $41.09M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $11.12M $17.54M
Accounts Receivable $27.41M $24.91M
Inventory $5.27M $4.32M
Other Current Assets $4.26M $6.11M
Total Current Assets $49.98M $52.88M
Property Plant & Equipment $80.51M $76.28M
Goodwill $58.46M $32.99M
Intangible Assets $1.35M $848.00K
Total Assets $202.36M $177.07M
Accrued Liabilities $25.01M $20.16M
Deferred Revenue $7.81M $6.69M
Total Current Liabilities $44.19M $37.33M
Long-term Debt $19.59M $3.59M
Total Liabilities $66.86M $43.77M
Common Stock $16.90M $23.36M
Retained Earnings $97.25M $89.69M
Total Stockholders Equity $133.61M $131.39M
Total Liabilities & Equity $202.36M $177.07M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $3.51M $1.48M $9.29M -
Depreciation & Amortization $397.00K - $21.04M -
Stock-based Compensation - - $6.83M -
Deferred Income Tax - - $2.73M -
Change in Receivables - - $670.00K -
Change in Inventory - - $163.00K -
Operating Cash Flow - - $33.48M -
Capital Expenditure - - $31.25M -
Acquisitions - - $26.33M -
Investing Cash Flow - - $-42.55M -
Stock Repurchased - - $13.22M -
Financing Cash Flow - - $2.66M -
Net Change in Cash - - $-6.42M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...